Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NTTG who wrote (12451)	9/25/2013 11:35:28 AM
From: Mimbari	Respond to of 13111

Ahhhh, but the injected lesions die. And still in many of the "immune compromised" patients the bystander effect works. So you would have it that the patients receive a crappy toxic drug and use PV-10 as a followup therapy? The bystander effect only works when PH-10 is used as the primary drug to destroy the tumor. You keep trying to discredit the drug and elevate your own standing in the medical community while doing so. However, what your ending up doing is showing how really ignorant you are and you will end up as an irrelevant footnote at the end which will read: "NTTG, a well balanced scientist with a chip on both shoulders, and an ignorant poster who tried to discredit PVCT but failed".